621 A Quality Care Dosing Guidelines
089 Adoptive Cell Therapies for Melanoma
246 Ampyra dalfampridine
021 Anti-Migraine Policy
054 Anti-Parkinsonism Drugs
013 Antihyperlipidemics
027 Antisense Oligonucleotide Medications
011 Asthma and Chronic Obstructive Pulmonary Disease Medication Management
621 B Quality Care Dosing Guidelines Drug List
006 Botulinum Toxin Injections
099 Carelon Oncology Medication Management Program
019 CNS Stimulants and Psychotherapeutic Agents
705 Compound Medications Exclusion Drug List
704 Compound Medications Inclusion Drug List
579 Compounded Medications
002 Cox II Inhibitor Drugs
041 Diabetes Step Therapy
049 Drug Management & Retail Pharmacy Prior Authorization Policy
251 Drug Management and Prior Authorization
408 Drugs for Cystic Fibrosis
092 Drugs for Macular Degeneration and Diabetic Eye Disease
572 Drugs for Weight Loss
023 E Form medication prior auth instruction
009 Elzonris (tagraxofusp-erzs) for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
213 Engineered T-Cell Therapy Synovial Sarcoma Policy
162 Entyvio ( Vedolizumab ) Policy
262 Erythropoietin, Recombinant Human and Hypoxia-Inducible Factor Inhibitors
087 Esketamine Nasal Spray (SpravatoTM) and Intravenous Ketamine for Mental Health Conditions
360 Factor and Non-Factor Anti-Hemophilic Drugs
360 Factor and Non-Factor Anti-Hemophilic Drugs
113 Fentanyl, oral-transmucosal
022 Gene Therapies for Duchenne Muscular Dystrophy
168 Gene Therapies for Hemophilia A or B
106 Gene Therapies for Metaloleukodystrophy
241 Gene Therapy for Cerebral Adrenoleukodystrophy SKYSONA
056 Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Related Drugs for the Treatment of Type 2 Diabetes
257 Growth Hormone and Insulin-like Growth Factor
063 Heart Failure and Hypertrophic Cardiomyopathy (HCM) Policy
697 HETLIOZ tasimelteon
430 Home Infusion Therapy Prior Authorization Form
296 Home Total Parenteral Nutrition TPN
131 Hypoactive Sexual Desire Disorder (HSDD) Policy
004 Immune Modulating Drugs
310 Immunoglobulins Policy
010 Immunomodulators for Skin Conditions
440 Influenza Drugs Tamiflu and Relenza
017 Injectable Asthma Medications
071 Injectable Specialty Medication Coverage
427 Injections for Osteoarthritis
052 Interferons Alpha and Gamma
434 Massachusetts Standard Form for Medication Prior Authorization Requests
034 Medical Benefit Prior Authorization Medication List
083 Medications for Sickle Cell and Beta Thalassemia
840 Methotrexate Step Therapy
946 Monoclonal Antibodies for Treatment of Alzheimer's Disease
839 Multiple Sclerosis Prior Auth Policy
062 Mupirocin Step Policy
005 New Drug Approval Program
433 Noncovered Drug List
123 Nononcologic Uses of Rituximab
409 Oncology Drugs
346 Ophthalmic Prostaglandins
102 Opioid Medication Management
170 Overactive Bladder Medications
344 Pharmacy Hepatitis C Medication Management
051 Pharmacy Specialty List
033 Pharmacy-MED_UM_Policy_SP
057 Pregabalin (Lyrica and Lyrica CR)
030 Proton Pump Inhibitors
422 RSV Immunoprophylaxis
093 Soliris, Ultomiris, Complement 3 Glomerulopathy (C3G), Myasthenia Gravis, Paroxysmal nocturnal hemoglobinuria (PNH), and Neuromyelitis Optica Policy
093 Soliris, Ultomiris, Complement 3 Glomerulopathy (C3G), Myasthenia Gravis, Paroxysmal nocturnal hemoglobinuria (PNH), and Neuromyelitis Optica Policy
304 Special Foods
044 Spinal Muscular Atrophy (SMA) Medications
681 Sublingual Immunotherapy with Allergen-specific Extracts - SLIT
105 Supportive Care Treatments for Patients with Cancer
426 Topical Ocular Hydrating Agents
345 Topical Testosterone
014 Veozah Step Policy
008 Zolgensma (onasemnogene abeparvovec-xioi) for Spinal Muscular Atrophy